ciprofloxacin has been researched along with diclofenac in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.79) | 18.7374 |
| 1990's | 3 (5.36) | 18.2507 |
| 2000's | 13 (23.21) | 29.6817 |
| 2010's | 29 (51.79) | 24.3611 |
| 2020's | 10 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Barecki, M; Casciano, CN; Clement, RP; Johnson, WW; Lew, K; Wang, E | 1 |
| Jolivette, LJ; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Avdeef, A; Tam, KY | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF | 1 |
| Eswaran, S; Narayanan, S; Shivarudraiah, P; Shruthi, TG; Subramanian, S | 1 |
| Caljon, G; Cappoen, D; Claes, P; Cools, F; Cos, P; De Kimpe, N; de Macedo, MB; Delputte, P; Holvoet, F; Maes, L; Mangelinckx, S; Matheeussen, A; Meiresonne, T; Neyrolles, O; Piller, T; Semina, E; Torfs, E; Van Calster, K | 1 |
| Rehavi, M; Rubinstein, E; Segev, S | 1 |
| MacKay, AD; Mehta, A | 1 |
| Bein, T; Ehret, W; Hobbhahn, J; Metz, C; Taeger, K | 1 |
| Makde, SD; Paranjpe, BD; Shrivastava, MP | 1 |
| Jayachandran, C; Kumar, N; Singh, SD | 1 |
| Bortel, LV; Remon, JP; Risha, PG; Vergote, G; Vervaet, C | 1 |
| Adler, S; Haas, H; Schostak, M; Walz, J | 1 |
| Cañada-Cañada, F; Espinosa-Mansilla, A; González Gómez, D; Muñoz de la Peña, A | 1 |
| Battikhi, MN; Battikhi, Q; Ismail, H | 1 |
| Iqbal, Z; Khan, A; Khan, GS; Khan, JA; Naz, A | 1 |
| Kim, J; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
| Andersohn, F; Bronder, E; Garbe, E; Grüneisen, A; Hildebrandt, M; Klimpel, A; Kurtal, H; Mayer, B; Salama, A; Schrezenmeier, H; Späth-Schwalbe, E; Thomae, M | 1 |
| Bhanger, MI; Khuhawar, MY; Mallah, A; Memon, N; Memon, SQ; Solangi, AR | 1 |
| Ammori, BJ; Ashcroft, DM; Darwich, AS; Jamei, M; Pade, D; Rostami-Hodjegan, A | 1 |
| De La Cruz Aguiló, RI; Marí Cotino, JF; Suriano, MM; Vila-Arteaga, J | 1 |
| Choonara, YE; du Toit, LC; Johnston, D; Kumar, P; Pillay, V | 1 |
| Haritova, AM; Krustev, SZ; Rusenova, NV | 1 |
| Choonara, YE; du Toit, LC; Johnston, D; Kumar, P; Pillay, V; van Vuuren, S | 1 |
| Cho, YH; Choe, HS; Han, CH; Lee, SJ; Shim, BS | 1 |
| Atkin, MS; Biri, H; Deniz, N; Kiraç, M | 1 |
| Chen, Y; Li, Y; Ling, ZL; Liu, L; Liu, XD; Shu, N; Sun, BB; Tang, XG; Wang, F; Xia, LZ; Xie, QS; Xu, P; Zhang, M; Zhao, KJ; Zhong, ZY | 1 |
| Philip, L; Ramanujam, S; Singh, RK | 1 |
| Anufrikov, YA; Bykova, AA; Chernova, EN; Eurov, DA; Fedorova, AV; Golubev, VG; Keltsieva, OA; Kurdyukov, DA; Podolskaya, EP; Russkikh, YV; Selyutin, AA; Shilovskikh, VV; Sokolov, VV; Sukhodolov, NG; Ubyivovk, EV | 1 |
| Acuña, V; Balcázar, JL; Borrego, CM; Sabater, S; Sànchez-Melsió, A; Subirats, J; Timoner, X | 1 |
| Chu, H; Guo, J; Yao, T; Zhang, Y; Zhou, X | 1 |
| Cavicchioli, M; Coelho, F; do Vale Braido, GV; Franchi, LP; Lima Ribeiro, SJ; Mendes, LS; Messaddeq, Y; O Capote, TS; Scarel-Caminaga, RM; Specian, SS | 1 |
| Alvarez-Lorenzo, C; Ares, AM; Carro, AM; Concheiro, A; Costoya, A; Lorenzo, RA; Muiño, R | 1 |
| Azevedo, OGR; Santiago, LA; Silva, JMRD; Vasconcelos, PRL | 1 |
| Alves, MM; Gomes, JC; Martins, G; Pereira, L; Salvador, AF; Silva, AR | 1 |
| Aboshanab, KM; Aboulwafa, MM; Ahmed, MT; Anwer, BE; Mohammed, MA | 1 |
| Narayanasamy, S; Pandian, S; Shahnaz, T; Vishnu Priyan, V | 1 |
| Arias-Moliz, MT; Baca, P; Ferrer-Luque, CM; Rodríguez-Archilla, A; Ruiz-Linares, M; Solana, C | 1 |
| Bhatnagar, A; Daneshvar, E; Eshaq, G; Maiti, A; Nakarmi, KJ; Nidheesh, PV; Puro, L; Wang, H | 1 |
| Bhayani, D; Khan, S; Mehta, P; Naik, H; Nathaniel, TN; Patel, M | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Akinsete, SJ; Egbeyemi, MM; Ewemoje, TA; Lateef, SA; Omobowale, MO | 1 |
| Ahmed-Anwar, AA; Farghali, AA; Hassouna, MEM; Mahmoud, R; Mohamed, MA | 1 |
3 review(s) available for ciprofloxacin and diclofenac
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recently reported biological activities of pyrazole compounds.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles | 2017 |
4 trial(s) available for ciprofloxacin and diclofenac
| Article | Year |
|---|---|
Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin and its interaction with diclofenac after intravenous administration in buffalo calves.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Buffaloes; Ciprofloxacin; Diclofenac; Drug Interactions; Enrofloxacin; Female; Fluoroquinolones; Injections, Intravenous; Quinolones | 2003 |
Drug formulations intended for the global market should be tested for stability under tropical climatic conditions.
Topics: Administration, Oral; Adult; Biological Availability; Chemistry, Pharmaceutical; Ciprofloxacin; Cross-Over Studies; Diclofenac; Drug Stability; Drug Storage; Hot Temperature; Humans; Humidity; Male; Solubility; Tablets; Temperature; Therapeutic Equivalency; Time Factors; Tropical Climate | 2003 |
Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
Topics: Adult; Chronic Disease; Ciprofloxacin; Diclofenac; Humans; Male; Pelvic Pain; Pilot Projects; Prospective Studies; Prostatitis; Roxithromycin; Treatment Outcome; Young Adult | 2014 |
Ureteroscopy: the first-line treatment for distally located ureteral stones smaller than 10 mm.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Female; Fluid Therapy; Humans; Male; Parasympatholytics; Prospective Studies; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urological Agents; Watchful Waiting; Young Adult | 2014 |
49 other study(ies) available for ciprofloxacin and diclofenac
| Article | Year |
|---|---|
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
Topics: 3T3 Cells; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Mice; Microsomes, Liver; Mixed Function Oxygenases; Molecular Structure; Substrate Specificity | 2001 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2019 |
The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Benzophenanthridines; Cell Line; Dose-Response Relationship, Drug; Humans; Hydrocarbons, Fluorinated; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2019 |
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
Topics: Animals; Ciprofloxacin; Diclofenac; Drug Synergism; GABA Antagonists; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Ofloxacin; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Theophylline | 1988 |
Autoimmune haemolytic anaemia associated with ciprofloxacin.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Bacteremia; Ciprofloxacin; Diclofenac; Female; Humans; Osteomyelitis; Salmonella Infections | 1995 |
[Severe legionellosis after abuse of anti-inflammatory drugs--diagnostic and intensive care aspects based on a case report].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow; Ciprofloxacin; Combined Modality Therapy; Critical Care; Diclofenac; Dipyrone; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immune Tolerance; Legionnaires' Disease; Liver Function Tests; Low Back Pain; Male; Middle Aged; Multiple Organ Failure; Opportunistic Infections | 1995 |
Interaction of ciprofloxacin with diclofenac and paracetamol in relation to it's epileptogenic effect.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Drug Synergism; Female; gamma-Aminobutyric Acid; Male; Mice; Seizures | 1997 |
[Prostate biopsy -- less pain through diclofenac].
Topics: Administration, Rectal; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Humans; Male; Pain; Placebos; Prostate; Randomized Controlled Trials as Topic; Time Factors; Ultrasonography | 2004 |
Determinations of fluoroquinolones and nonsteroidal anti-inflammatory drugs in urine by extractive spectrophotometry and photoinduced spectrofluorimetry using multivariate calibration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry Techniques, Analytical; Ciprofloxacin; Diclofenac; Fluoroquinolones; Humans; Least-Squares Analysis; Mefenamic Acid; Ofloxacin; Photochemistry; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry; Spectrophotometry, Ultraviolet | 2005 |
Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Ciprofloxacin; Diclofenac; Enterobacteriaceae Infections; Gonorrhea; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Diseases; Pseudomonas Infections; Staphylococcal Infections | 2006 |
Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Cross-Over Studies; Diclofenac; Drug Combinations; Drug Interactions; Half-Life; Humans; Metabolic Clearance Rate; Tablets; Tissue Distribution; Young Adult | 2009 |
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Dioxolanes; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Phenylacetates; Piperazines; Receptors, GABA-A; Seizures | 2009 |
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Berlin; beta-Lactams; Case-Control Studies; Ciprofloxacin; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lorazepam; Male; Middle Aged; Odds Ratio; Piperacillin; Population Surveillance; Trimethoprim, Sulfamethoxazole Drug Combination; Vidarabine; Young Adult | 2011 |
Development and implication of a capillary electrophoresis methodology for ciprofloxacin, paracetamol and diclofenac sodium in pharmaceutical formulations and simultaneously in human urine samples.
Topics: Acetaminophen; Buffers; Calibration; Ciprofloxacin; Diclofenac; Electricity; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets; Time Factors | 2011 |
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.
Topics: Administration, Oral; Bariatric Surgery; Biological Availability; Chemistry, Pharmaceutical; Ciprofloxacin; Computer Simulation; Cytochrome P-450 CYP3A; Diclofenac; Fluconazole; Humans; Intestinal Mucosa; Models, Biological; Obesity, Morbid; Omeprazole; Permeability; Pharmaceutical Preparations; Simvastatin; Solubility | 2012 |
Central toxic keratopathy: a clinical case series.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Astigmatism; Ciprofloxacin; Corneal Opacity; Dexamethasone; Diclofenac; Disease Progression; Female; Gloves, Surgical; Glucocorticoids; Humans; Keratomileusis, Laser In Situ; Male; Myopia; Postoperative Complications; Retrospective Studies | 2013 |
Modulation of the nano-tensile mechanical properties of co-blended amphiphilic alginate fibers as oradurable biomaterials for specialized biomedical application.
Topics: Alginates; Anti-Infective Agents; Anti-Inflammatory Agents; Biocompatible Materials; Ciprofloxacin; Dental Materials; Diclofenac; Drug Carriers; Elastic Modulus; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Materials Testing; Nanotechnology; Polymers; Stress, Mechanical; Tensile Strength | 2013 |
Effect of diclofenac on ocular levels of ciprofloxacin and lomefloxacin in rabbits with endophthalmitis.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Drug Interactions; Endophthalmitis; Fluoroquinolones; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections | 2014 |
Prolonged delivery of ciprofloxacin and diclofenac sodium from a polymeric fibre device for the treatment of periodontal disease.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diclofenac; Drug Delivery Systems; Enterococcus faecalis; Escherichia coli; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Periodontal Diseases; Polymers; Streptococcus mutans | 2013 |
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Ciprofloxacin; Diclofenac; Dose-Response Relationship, Drug; Drug Interactions; Enterohepatic Circulation; Escherichia coli; Glucuronidase; Intestinal Diseases; Intestine, Small; Liver; Male; Rats | 2016 |
Rapid degradation, mineralization and detoxification of pharmaceutically active compounds in aqueous solution during pulsed corona discharge treatment.
Topics: Chromatography, Liquid; Ciprofloxacin; Diclofenac; Mass Spectrometry; Water Pollutants, Chemical | 2017 |
Ni-functionalized submicron mesoporous silica particles as a sorbent for metal affinity chromatography.
Topics: Adsorption; Benzoic Acid; Chromatography, Affinity; Ciprofloxacin; Diclofenac; Kinetics; Metals; Microscopy, Electron, Transmission; Nickel; Particle Size; Porosity; Silicon Dioxide; Spectrometry, X-Ray Emission; Temperature; Time Factors | 2017 |
Emerging contaminants and nutrients synergistically affect the spread of class 1 integron-integrase (intI1) and sul1 genes within stable streambed bacterial communities.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Ciprofloxacin; Diclofenac; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Integrases; Parabens; Rivers; Sulfamethoxazole; Wastewater; Water Pollutants | 2018 |
The influence of four pharmaceuticals on Chlorellapyrenoidosa culture.
Topics: Carbamazepine; Catalase; Cell Culture Techniques; Chlorella; Chlorophyll A; Ciprofloxacin; Clofibric Acid; Diclofenac; Dose-Response Relationship, Drug; Lipid Metabolism; Metabolomics; Microalgae; Particle Size; Pharmaceutical Preparations; Superoxide Dismutase | 2019 |
Toxicity of therapeutic contact lenses based on bacterial cellulose with coatings to provide transparency.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cellulose; CHO Cells; Ciprofloxacin; Coated Materials, Biocompatible; Comet Assay; Contact Lenses, Hydrophilic; Cricetulus; Diclofenac; Drug Delivery Systems; Excipients; gamma-Cyclodextrins; Gluconacetobacter xylinus; Micronucleus Tests | 2019 |
Cyclodextrin-functionalized cellulose filter paper for selective capture of diclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biodegradation, Environmental; Cellulose; Ciprofloxacin; Cyclodextrins; Diclofenac; Filtration; Salinity; Water; Water Pollutants, Chemical; Water Purification | 2019 |
Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Conjunctivitis, Viral; Diclofenac; Female; Humans; Interferon-gamma; Interleukins; Lubricant Eye Drops; Male; Middle Aged; Nitric Oxide Synthase; Ophthalmic Solutions; Prednisolone; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Ciprofloxacin, diclofenac, ibuprofen and 17α-ethinylestradiol differentially affect the activity of acetogens and methanogens in anaerobic communities.
Topics: Anaerobiosis; Bacteria; Ciprofloxacin; Diclofenac; Ethinyl Estradiol; Ibuprofen; Microbiota; Wastewater; Water Pollutants, Chemical | 2020 |
Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Chlorpromazine; Ciprofloxacin; Cross Infection; Diclofenac; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Egypt; Fluoroquinolones; Humans; Levofloxacin; Propranolol | 2020 |
Use of Nanocellulose extracted from grass for adsorption abatement of Ciprofloxacin and Diclofenac removal with phyto, and fish toxicity studies.
Topics: Adsorption; Ciprofloxacin; Diclofenac; Hydrogen-Ion Concentration; Kinetics; Poaceae; Thermodynamics; Water Pollutants, Chemical | 2021 |
Antibiofilm Activity of Diclofenac and Antibiotic Solutions in Endodontic Therapy.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Dentin; Diclofenac; Enterococcus faecalis; Microscopy, Confocal; Minocycline | 2021 |
Synthesis of biochar from iron-free and iron-containing microalgal biomass for the removal of pharmaceuticals from water.
Topics: Adsorption; Biomass; Charcoal; Ciprofloxacin; Diclofenac; Kinetics; Microalgae; Pharmaceutical Preparations; Spectroscopy, Fourier Transform Infrared; Water; Water Pollutants, Chemical | 2022 |
Ground-based selected ionizing space radiation effects on stability of APIs and their formulations.
Topics: Ciprofloxacin; Diclofenac; Metoprolol; Protons; Radiation, Ionizing; Space Flight; Tablets | 2022 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Health risk assessment for uptake and accumulation of pharmaceuticals in jute mallow (Corchorus olitorius) irrigated with treated hospital wastewater.
Topics: Acetaminophen; Agricultural Irrigation; Anti-Bacterial Agents; Ciprofloxacin; Corchorus; Diclofenac; Environmental Monitoring; Humans; Ibuprofen; Pharmaceutical Preparations; Risk Assessment; Soil; Soil Pollutants; Sulfamethoxazole; Tetracyclines; Wastewater; Water | 2023 |
Green UPLC method for estimation of ciprofloxacin, diclofenac sodium, and ibuprofen with application to pharmacokinetic study of human samples.
Topics: Acetonitriles; Chromatography, High Pressure Liquid; Ciprofloxacin; Diclofenac; Humans; Ibuprofen; Reproducibility of Results; Tandem Mass Spectrometry | 2023 |